Literature DB >> 21334895

Biotin tethered homotryptamine derivatives: high affinity probes of the human serotonin transporter (hSERT).

Ian D Tomlinson1, Hideki Iwamoto, Randy D Blakely, Sandra J Rosenthal.   

Abstract

Quantum dot conjugates of compounds capable of inhibiting the serotonin transporter (SERT) could form the basis of fluorescent probes for live cell imaging of membrane bound SERT. Additionally, quantum dot-SERT antagonist conjugates may be amenable to fluorescence-based, high-throughput assays for this transporter. This Letter describes the synthesis of SERT-selective ligands amenable to conjugation to quantum dots via a biotin-streptavidin binding interaction. SERT selectivity and affinity were incorporated into the ligand via a tetrahydropyridine or cyclohexylamine derivative and the affinity of these compounds for SERT was measured by their ability to produce SERT-dependent currents in Xenopus laveis oocytes.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334895      PMCID: PMC3070488          DOI: 10.1016/j.bmcl.2011.01.102

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Surface modification to reduce nonspecific binding of quantum dots in live cell assays.

Authors:  Elizabeth L Bentzen; Ian D Tomlinson; John Mason; Paul Gresch; Michael R Warnement; David Wright; Elaine Sanders-Bush; Randy Blakely; Sandra J Rosenthal
Journal:  Bioconjug Chem       Date:  2005 Nov-Dec       Impact factor: 4.774

2.  Structural basis for near unity quantum yield core/shell nanostructures.

Authors:  James McBride; Joe Treadway; L C Feldman; Stephen J Pennycook; Sandra J Rosenthal
Journal:  Nano Lett       Date:  2006-07       Impact factor: 11.189

3.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection.

Authors:  W C Chan; S Nie
Journal:  Science       Date:  1998-09-25       Impact factor: 47.728

4.  Semiconductor nanocrystals as fluorescent biological labels.

Authors:  M Bruchez; M Moronne; P Gin; S Weiss; A P Alivisatos
Journal:  Science       Date:  1998-09-25       Impact factor: 47.728

5.  Synthesis, Surface Studies, Composition and Structural Characterization of CdSe, Core/Shell, and Biologically Active Nanocrystals.

Authors:  Sandra J Rosenthal; James McBride; Stephen J Pennycook; Leonard C Feldman
Journal:  Surf Sci Rep       Date:  2007-04-30       Impact factor: 12.267

6.  Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots.

Authors:  Ian D Tomlinson; John N Mason; Randy D Blakely; Sandra J Rosenthal
Journal:  Bioorg Med Chem Lett       Date:  2005-09-23       Impact factor: 2.823

7.  Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies.

Authors:  Y Qian; H E Melikian; D B Rye; A I Levey; R D Blakely
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

8.  Targeting cell surface receptors with ligand-conjugated nanocrystals.

Authors:  Sandra J Rosenthal; Ian Tomlinson; Erika M Adkins; Sally Schroeter; Scott Adams; Laura Swafford; James McBride; Yongqiang Wang; Louis J DeFelice; Randy D Blakely
Journal:  J Am Chem Soc       Date:  2002-05-01       Impact factor: 15.419

9.  Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dots.

Authors:  Ian D Tomlinson; Michael R Warnerment; John N Mason; Matthew J Vergne; David M Hercules; Randy D Blakely; Sandra J Rosenthal
Journal:  Bioorg Med Chem Lett       Date:  2007-08-21       Impact factor: 2.823

10.  Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.

Authors:  Jeffrey A Deskus; James R Epperson; Charles P Sloan; Joseph A Cipollina; Pierre Dextraze; Jingfang Qian-Cutrone; Qi Gao; Baoqing Ma; Brett R Beno; Gail K Mattson; Thaddeus F Molski; Rudolph G Krause; Matthew T Taber; Nicholas J Lodge; Ronald J Mattson
Journal:  Bioorg Med Chem Lett       Date:  2007-03-16       Impact factor: 2.823

View more
  5 in total

1.  Single-quantum-dot tracking reveals altered membrane dynamics of an attention-deficit/hyperactivity-disorder-derived dopamine transporter coding variant.

Authors:  Oleg Kovtun; Dhananjay Sakrikar; Ian D Tomlinson; Jerry C Chang; Xochitl Arzeta-Ferrer; Randy D Blakely; Sandra J Rosenthal
Journal:  ACS Chem Neurosci       Date:  2015-03-16       Impact factor: 4.418

2.  Identification of a novel selective serotonin reuptake inhibitor by coupling monoamine transporter-based virtual screening and rational molecular hybridization.

Authors:  Tammy L Nolan; David J Lapinsky; Jeffery N Talbot; Martín Indarte; Yi Liu; Sankar Manepalli; Laura M Geffert; Mary Ellen Amos; Phillip N Taylor; Jeffry D Madura; Christopher K Surratt
Journal:  ACS Chem Neurosci       Date:  2011-06-08       Impact factor: 4.418

3.  A fluorescence displacement assay for antidepressant drug discovery based on ligand-conjugated quantum dots.

Authors:  Jerry C Chang; Ian D Tomlinson; Michael R Warnement; Hideki Iwamoto; Louis J DeFelice; Randy D Blakely; Sandra J Rosenthal
Journal:  J Am Chem Soc       Date:  2011-10-17       Impact factor: 15.419

4.  Quantum dot conjugates of GABA and muscimol: binding to α1β2γ2 and ρ1 GABA(A) receptors.

Authors:  Hélène A Gussin; Ian D Tomlinson; Dingcai Cao; Haohua Qian; Sandra J Rosenthal; David R Pepperberg
Journal:  ACS Chem Neurosci       Date:  2013-01-11       Impact factor: 4.418

5.  Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells.

Authors:  Y S Singh; S C Altieri; T L Gilman; H M Michael; I D Tomlinson; S J Rosenthal; G M Swain; M A Murphey-Corb; R E Ferrell; A M Andrews
Journal:  Transl Psychiatry       Date:  2012-02-07       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.